CANADA LIFE ASSURANCE Co Sells 12,227 Shares of Select Medical Holdings Co. (NYSE:SEM)

CANADA LIFE ASSURANCE Co cut its stake in Select Medical Holdings Co. (NYSE:SEMFree Report) by 9.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 115,125 shares of the health services provider’s stock after selling 12,227 shares during the period. CANADA LIFE ASSURANCE Co’s holdings in Select Medical were worth $2,170,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Smartleaf Asset Management LLC lifted its holdings in Select Medical by 179.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider’s stock valued at $43,000 after buying an additional 1,473 shares during the period. Wilmington Savings Fund Society FSB bought a new position in shares of Select Medical during the 3rd quarter worth approximately $81,000. Covestor Ltd increased its stake in shares of Select Medical by 33.5% in the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider’s stock valued at $93,000 after acquiring an additional 1,244 shares in the last quarter. Cibc World Markets Corp acquired a new position in shares of Select Medical during the 4th quarter valued at $191,000. Finally, Vista Finance LLC acquired a new stake in Select Medical in the fourth quarter worth $193,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Stock Performance

NYSE SEM opened at $17.40 on Monday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a market capitalization of $2.24 billion, a PE ratio of 10.55, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. Select Medical Holdings Co. has a 52-week low of $14.99 and a 52-week high of $40.98. The company has a 50-day simple moving average of $17.04 and a 200 day simple moving average of $22.23.

Select Medical (NYSE:SEMGet Free Report) last posted its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. On average, research analysts predict that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.44%. The ex-dividend date of this dividend was Monday, March 3rd. Select Medical’s dividend payout ratio (DPR) is currently 15.15%.

Analysts Set New Price Targets

Several brokerages have recently commented on SEM. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an “outperform” rating and a $25.00 target price for the company. Royal Bank of Canada decreased their price objective on Select Medical from $47.00 to $23.00 and set an “outperform” rating for the company in a report on Monday, February 24th. UBS Group reduced their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, February 21st. Finally, Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research note on Monday, February 24th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Select Medical has a consensus rating of “Moderate Buy” and a consensus target price of $26.80.

Read Our Latest Analysis on Select Medical

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Articles

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.